logo
logo

X-COR Therapeutics, an Alira Health Ventures Portfolio Company, Closes Initial $2.6M Funding Round.

Nov 12, 2020•over 4 years ago

Amount Raised

$2 Million

Round Type

seed

FraminghamProfessional ServicesHealth Care

Description

Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials. Alira Health’s investment arm, Alira Health Ventures, added X-COR Therapeutics in 2019 as a portfolio company and led the recent seed financing with syndication from Good Growth Capital, PiSA Biopharm, Flybridge Partners’ Graduate Syndicate, and other notable angel investors.

Company Information

Company

X Cor Therapeutics:

Location

Framingham, Massachusetts, United States

About

Alira Health is an international patient-centric and technology-enabled advisory firm on the frontlines of healthcare transformation. We provide a suite of integrated services designed to help healthcare and life science companies innovate and grow across their solutions lifecycle. Alira Health was founded in 1999 and is based in Framingham, MA, U.S. Alira Health has offices in San Francisco, CA, U.S.; Paris, France; Barcelona, Spain; Munich, Germany; Milan, Bologna and Verona, Italy; and Basel and Geneva, Switzerland; and Cambridge, UK. Learn more at https://www.alirahealth.com/.

Related People